Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL STEM CELL MARKET FORECAST 2022-2030

GLOBAL STEM CELL MARKET FORECAST 2022-2030

In terms of revenue, the global stem cell market was valued at $10192.70 million in 2021 and is expected to reach $21901.02 million by 2030, growing at a CAGR of 8.88% during the forecast period of 2022 to 2030.

GLOBAL STEM CELL MARKET FORECAST 2022-2030

Global Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) Market by Product (Adult Stem Cell, Human Embryonic Stem Cell, Pluripotent, Mouse/Rat Neural) Market by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture) By Geography

Request free sample

In terms of revenue, the global stem cell market was valued at $10192.70 million in 2021 and is expected to reach $21901.02 million by 2030, growing at a CAGR of 8.88% during the forecast period of 2022 to 2030.

To know more about this report, request a free sample copy

The paracrine promotion of wound healing and cutaneous tissue regeneration are two areas where stem cells hold great promise. In-depth research is also being conducted on numerous cell types, including mesenchymal stem cells, embryonic stem cells, epithelial stem cells, resident tissue stem cells, hematopoietic stem cells and adipose-derived stem cells. As a result, this factor could lead to significant growth in the stem cell market.

Furthermore, as the world’s population gradually gets older, the prevalence of chronic diseases is set to rise. However, this places tremendous strain on the global healthcare system. Hence, the market for stem cells, in addition to the number of clinical trials being conducted, is expanding in order to reduce the burden of diseases worldwide.

Stem Cell Market

Read our latest blog on the Stem Cell Market

Key growth enablers of the global stem cell market:

  • Surging demand for stem cells in regenerative medicine
  • Growing R&D investments in stem cell therapies and research
    • A variety of diseases for which there are no known cures may be treated using stem cells. They can also be utilized to restore neurons that have been damaged by neurological issues such as Parkinson’s disease, Alzheimer’s disease, and spinal cord injuries.
    • As per the Australian Government Department of Health 2019, the stem cell therapy mission was launched by the government of Australia. It is a research funding program with an investment of around USD 150 million over 9 years. The mission aims to develop innovative, safe, and effective treatments for patients suffering from incurable diseases
    • According to the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), 2018, there are currently more than 6,000 records associated with stem cell research, with about more than 200 clinical trials in the phase-III stage of development and currently recruiting patients
  • Rising awareness about umbilical cord stem cells
  • Reduced risk of tissue rejection in transplants

Key growth restraining factors:

  • Absence of a well-defined regulatory framework for stem cell therapy
    • Unregulated clinics promising stem cell therapies for conditions such as Parkinson’s disease, muscular dystrophy, Alzheimer’s disease, and spinal cord injuries are increasing in nations like China, Mexico, and Argentina.
    • Such unapproved, uncontrolled methods of administering stem cell therapy could hinder the market expansion for mesenchymal stem cells.
    • Also, several restrictions are in place for utilization based on reimbursement issues, practice guidelines, payer contract restrictions, selection of appropriate information, and consent procedures for different research protocols.
  • High costs associated with stem cell procedures
  • Ethical issues and social complexities
  • Less responsiveness in developed economies

Global Stem Cell Market | Top Trends

  • In March 2020, about 14 trials utilizing stem cells for treating SARS-COV-2 infection were conducted in China. This has resulted in doctors’ increasing interest in the use of mesenchymal stem cells (MSC-based) therapy to manage COVID-19 since 2020.
  • Degenerative illnesses lead to enormous cell death and subsequently result in the failure of crucial organs (e.g., heart, central nervous system, and others). This has further led to stem cells emerging as a drug delivery tool. Moreover, the direct evaluation of a drug’s efficacy and side effects would be possible by testing lead compounds for neuronal, liver, and cardiac toxicity, as well.
  • Compared to bone marrow, umbilical cord blood has benefits such as the ability to be utilized allogeneically and the lack of need for exact human leukocyte antigen (HLA) tissue matching. Besides, it is simpler and less expensive to collect MSC-like cells from tissues discarded at birth than to aspirate bone marrow for MSCs. This factor leads to a rise in cases of preservation of cord stem cells after birth.

Market Segmentation – Therapeutic Application, Product, Technology, Application, and Treatment Type –

Market by Therapeutic Application:

  • Orthopedic Treatments
    • The orthopedic treatments segment, under the therapeutic application category, is expected to grow with the highest CAGR during the forecast period.
    • Stem cells have played a key role in orthopedic regenerative medicine, primarily in terms of healing the body without invasive surgery. Although orthopedic treatment applications in stem cell therapies are still evolving, recent research has shown positive results, likely to drive the stem cell market growth in the future.
    • Clinical trials of stem cell therapy have exhibited significant success in bone fractures, damaged articular cartilage, and injuries to the connective tissue, such as tendons and ligaments.
    • Furthermore, in July 2019, Personalized Stem Cells (PSC), a human adipose-derived stem cell company, announced the FDA approval of a new drug (IND) application for treating osteoarthritis with stem cells.
  • Injuries & Wounds
  • Oncology Disorders
  • Cardiovascular Disorders
  • Neurological Disorders
  • Diabetes
  • Other Therapeutic Applications

Market by Product:

  • Adult Stem Cell
    • Hematopoietic Stem Cell
    • Neural Stem Cell
    • Umbilical Cord Stem Cell
    • Mesenchymal Stem Cell
    • Dental Stem Cell
  • Human Embryonic Stem Cell
  • Pluripotent
  • Mouse/Rat Neural

Market by Technology:

  • Cell Acquisition
    • Bone Marrow Harvest
    • Umbilical Cord
    • Apheresis
  • Cell Production
    • Therapeutic Cloning
    • In Vitro Fertilization (IVF)
    • Cell Culture
    • Isolation
  • Cryopreservation
  • Expansion & Sub-Culture

Market by Application:

  • Regenerative Medicine
  • Drug Discovery and Development
    • Drug discovery and development is anticipated to be the leading application during the forecast years.
    • A new direction in medication development and discovery has been made possible by stem cell treatment. As a result of stem cell therapy, it is now possible to expand the methods for identifying and developing novel medications from lead compounds, and to regard stem cells as a potential resource for dealing with medical issues.
    • A team of researchers enhanced a medication currently used to treat a genetic cardiac rhythm condition in 2020, according to an article published in the journal Cell Stem Cell. This endeavor could expedite the creation of medications to treat diverse genetic heart illnesses.
    • According to this method, the hiPSC-cardiomyocytes may facilitate rapid testing of novel drugs intended to treat specific hereditary cardiac defects such as congenital long-QT syndrome.

Market by Treatment Type:

  • Allogenic Stem Cell Therapy
  • Autologic Stem Cell Therapy
  • Syngeneic Stem Cell Therapy

Geographical Study Based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia & New Zealand, South Korea, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
    • The Asia-Pacific is anticipated to be the fastest-growing regional market over the estimated years.
    • The region’s market growth is attributed to emerging nations investing heavily in healthcare and medical facilities, along with superior resources, as well as a talent pool of scientists and doctors with increasing experience.
    • Medical tourism is on the rise in developing nations like India and China, with patients from the United States and Europe choosing to receive affordable yet high-quality care in the aforementioned regions. Furthermore, a thriving contract research sector and the high prevalence of chronic diseases play a pivotal role in facilitating the Asia-Pacific stem cell market growth.
    • In its most recent five-year plan, China’s government allocated $18 billion to biotechnology research in 2019, providing the country with the greatest market share of 25.21% in 2021.
    • On the other hand, in Chandigarh, the Global Institute of Stem Cell Therapy and Research (GIOSTAR) opened a center for cancer research and therapy using stem cells in 2020. Besides, some of the other factors influencing the region’s market include the support provided by the government and increasing awareness.
  • Rest of World: Latin America, the Middle East & Africa

Major players in the global stem cell market:

  • Corning Inc
  • GE Healthcare
  • Merck KGaA (Sigma Aldrich)
  • Qiagen
  • Smith+Nephew PLC

Key strategies adopted by some of these companies:

In February 2022, to further branch out into the diagnosis of blood cancer, monitoring research for blood diseases, and the detection of minimal residual disease (MRD), Becton Dickinson and Company announced the completion of the acquisition of Cytognos, a privately held company with its headquarters in the Salamanca region of Spain.

In March 2022, PBS Biotech Inc and Stemcell Technologies Inc announced their collaboration to produce the PBS-MINI Bioreactor and provide it to researchers wishing to scale up their human pluripotent stem cell (hPSC) cultures through Stemcell Technologies.

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Therapeutic Application, Product, Technology, Application, and Treatment Type
Geographies Analyzed North America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

AllCells LLC, Becton, Dickinson and Company, Corning Inc, Lorem Cytori Inc, GE Healthcare, International Stem Cell Corporation (ISCO), Merck KGaA (Sigma Aldrich), Miltenyi Biotec, Pluri Inc, Qiagen, Smith+Nephew PLC, Stemcell Technologies Inc, Stryker Corporation, Takara Holdings Inc, Thermo Fisher Scientific Inc

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • SURGING DEMAND FOR STEM CELLS IN REGENERATIVE MEDICINE
      • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES & RESEARCH
      • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
      • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • KEY RESTRAINTS
      • ABSENCE OF A WELL-DEFINED REGULATORY FRAMEWORK FOR STEM CELL THERAPY
      • HIGH COSTS ASSOCIATED WITH STEM CELL PROCEDURES
      • ETHICAL ISSUES AND SOCIAL COMPLEXITIES
      • LESS RESPONSIVENESS IN DEVELOPED ECONOMIES
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON STEM CELL MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • PRICE
      • EFFICACY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • REGULATORY FRAMEWORK
  2. MARKET BY THERAPEUTIC APPLICATION
    • ORTHOPEDIC TREATMENTS
    • INJURIES & WOUNDS
    • ONCOLOGY DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • DIABETES
    • OTHER THERAPEUTIC APPLICATIONS
  3. MARKET BY PRODUCT
    • ADULT STEM CELL
      • HEMATOPOIETIC STEM CELL
      • NEURAL STEM CELL
      • UMBILICAL CORD STEM CELL
      • MESENCHYMAL STEM CELL
      • DENTAL STEM CELL
    • HUMAN EMBRYONIC STEM CELL
    • PLURIPOTENT
    • MOUSE/RAT NEURAL
  4. MARKET BY TECHNOLOGY
    • CELL ACQUISITION
      • BONE MARROW HARVEST
      • UMBILICAL CORD
      • APHERESIS
    • CELL PRODUCTION
      • THERAPEUTIC CLONING
      • IN VITRO FERTILIZATION (IVF)
      • CELL CULTURE
      • ISOLATION
    • CRYOPRESERVATION
    • EXPANSION & SUB-CULTURE
  5. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  6. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • ACQUISITIONS
      • PARTNERSHIPS
    • COMPANY PROFILES
      • ALLCELLS LLC
      • BECTON, DICKINSON AND COMPANY (BD)
      • CORNING INC
      • GE HEALTHCARE
      • INTERNATIONAL STEM CELL CORPORATION
      • LOREM CYTORI INC
      • MERCK KGAA (SIGMA ALDRICH)
      • MILTENYI BIOTEC
      • PLURI INC
      • QIAGEN
      • SMITH+NEPHEW PLC
      • STEMCELL TECHNOLOGIES INC
      • STRYKER CORPORATION
      • TAKARA HOLDINGS INC
      • THERMO FISHER SCIENTIFIC INC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – STEM CELL

TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 6: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 8: GLOBAL INJURIES & WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: GLOBAL INJURIES & WOUNDS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 10: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 12: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 13: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 14: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 15: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 16: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 17: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 18: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 19: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 20: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 21: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 22: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 23: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 26: GLOBAL NEURAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 27: GLOBAL NEURAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 42: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 43: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 44: GLOBAL BONE MARROW HARVEST MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 45: GLOBAL BONE MARROW HARVEST MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 46: GLOBAL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 47: GLOBAL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 48: GLOBAL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 49: GLOBAL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 50: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 51: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 52: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 53: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 54: GLOBAL IN VITRO FERTILIZATION (IVF) MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 55: GLOBAL IN VITRO FERTILIZATION (IVF) MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 56: GLOBAL CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 57: GLOBAL CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 58: GLOBAL ISOLATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 59: GLOBAL ISOLATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 60: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62: GLOBAL EXPANSION & SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 63: GLOBAL EXPANSION & SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 64: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 65: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 66: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 67: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 68: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 69: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 70: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 71: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 72: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 73: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 74: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 75: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 76: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 77: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 78: GLOBAL STEM CELL MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 79: GLOBAL STEM CELL MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 80: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 81: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 82: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET

TABLE 83: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 84: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 85: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET

TABLE 86: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 87: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 88: LEADING PLAYERS OPERATING IN ASIA-PACIFIC STEM CELL MARKET

TABLE 89: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 90: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 91: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

TABLE 92: LIST OF ACQUISITIONS

TABLE 93: LIST OF PARTNERSHIPS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: KEY BUYING CRITERIA

FIGURE 8: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021

FIGURE 9: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL STEM CELL MARKET, BY DIABETES, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

FIGURE 17: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021

FIGURE 19: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 28: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021

FIGURE 30: GLOBAL STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2030 (IN $ MILLION)

FIGURE 31: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD, 2022-2030 (IN $ MILLION)

FIGURE 32: GLOBAL STEM CELL MARKET, BY APHERESIS, 2022-2030 (IN $ MILLION)

FIGURE 33: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, 2022-2030 (IN $ MILLION)

FIGURE 34: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021

FIGURE 35: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2030 (IN $ MILLION)

FIGURE 36: GLOBAL STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2030 (IN $ MILLION)

FIGURE 37: GLOBAL STEM CELL MARKET, BY CELL CULTURE, 2022-2030 (IN $ MILLION)

FIGURE 38: GLOBAL STEM CELL MARKET, BY ISOLATION, 2022-2030 (IN $ MILLION)

FIGURE 39: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2030 (IN $ MILLION)

FIGURE 40: GLOBAL STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2030 (IN $ MILLION)

FIGURE 41: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

FIGURE 42: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)

FIGURE 43: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2030 (IN $ MILLION)

FIGURE 44: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021

FIGURE 45: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 46: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 47: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 48: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 49: UNITED STATES STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: CANADA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 51: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 52: UNITED KINGDOM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 53: GERMANY STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 54: FRANCE STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 55: ITALY STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 56: BELGIUM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 57: POLAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 58: REST OF EUROPE STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 59: ASIA-PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

FIGURE 60: CHINA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 61: JAPAN STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 62: INDIA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 63: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 64: SOUTH KOREA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 65: THAILAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 66: INDONESIA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 67: VIETNAM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 68: REST OF ASIA-PACIFIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 69: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 70: LATIN AMERICA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 71: MIDDLE EAST & AFRICA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY THERAPEUTIC APPLICATION
    • ORTHOPEDIC TREATMENTS
    • INJURIES & WOUNDS
    • ONCOLOGY DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • DIABETES
    • OTHER THERAPEUTIC APPLICATIONS
  2. MARKET BY PRODUCT
    • ADULT STEM CELL
      • HEMATOPOIETIC STEM CELL
      • NEURAL STEM CELL
      • UMBILICAL CORD STEM CELL
      • MESENCHYMAL STEM CELL
      • DENTAL STEM CELL
    • HUMAN EMBRYONIC STEM CELL
    • PLURIPOTENT
    • MOUSE/RAT NEURAL
  3. MARKET BY TECHNOLOGY
    • CELL ACQUISITION
      • BONE MARROW HARVEST
      • UMBILICAL CORD
      • APHERESIS
    • CELL PRODUCTION
      • THERAPEUTIC CLONING
      • IN VITRO FERTILIZATION (IVF)
      • CELL CULTURE
      • ISOLATION
    • CRYOPRESERVATION
    • EXPANSION & SUB-CULTURE
  4. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  5. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions (FAQs):

    Which country is set to have the highest growth potential by 2030 in the Asia-Pacific stem cell market?

    India is expected to show the highest growth potential in the Asia-Pacific stem cell market by 2030.

    Which applications are expected to drive the demand across the global stem cell market?

    Applications such as the use of stem cells for regenerative medicine and drug discovery and development are expected to drive the demand across the global stem cell market.

    Which is a notable trend in the global stem cell market?

    The rise in successful collaborations between Asian governments, international health agencies, as well as private companies is a key trend in the global stem cell market.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type